StockData
Caris Life Sciences, Inc. logo

Caris Life Sciences, Inc. (CAI) stock

CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3093% above fair value
$19.94−1.06 (-5.05%)

Close on Nov 17, 2026Market cap $5.63BP/E –Yield –

Caris Life Sciences cash

Cash and short-term investments held at the end of each period.

Caris Life Sciences's cash was $822.22M at Mar 31, 2026. For fiscal 2025 it was $798.57M, up 1107.2% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$798.57M+1107.2%
FY2024Dec 31, 2024$66.15M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$822.22M+2535.2%
Q4 FY2025Dec 31, 2025$798.57M+1107.2%
Q3 FY2025Sep 30, 2025$755.49M–
Q2 FY2025Jun 30, 2025$721.18M–
Q1 FY2025Mar 31, 2025$31.20M–
Q4 FY2024Dec 31, 2024$66.15M–

More Caris Life Sciences figures

See a number that looks wrong?